Mackenzie Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.26M	Buy	101,337 +44,063	+77%	+$1.05M	﹤0.01%	897
2025 Q4	$1.53M	Buy	57,274 +3,917	+7%	+$93.6K	﹤0.01%	950
2025 Q3	$1.14M	Hold	53,357	–	–	﹤0.01%	1033
2025 Q2	$1.15M	Sell	53,357 -5,022	-9%	-$93.3K	﹤0.01%	980
2025 Q1	$970K	Buy	58,379 +7,314	+14%	+$133K	﹤0.01%	991
2024 Q4	$937K	Buy	51,065 +32,833	+180%	+$530K	﹤0.01%	954
2024 Q3	$280K	Sell	18,232 -1,668	-8%	-$27.8K	﹤0.01%	1223
2024 Q2	$323K	Sell	19,900 -37,839	-66%	-$611K	﹤0.01%	1144
2024 Q1	$1.07M	Buy	57,739 +4,760	+9%	+$118K	﹤0.01%	863
2023 Q4	$1.66M	Buy	52,979 +39,460	+292%	+$942K	﹤0.01%	763
2023 Q3	$281K	Sell	13,519 -10,143	-43%	-$275K	﹤0.01%	1161
2023 Q2	$568K	Buy	23,662 +10,325	+77%	+$230K	﹤0.01%	983
2023 Q1	$251K	Sell	13,337 -1,254	-9%	-$23.9K	﹤0.01%	1256
2022 Q4	$232K	Sell	14,591 -19,221	-57%	-$300K	﹤0.01%	1181
2022 Q3	$553K	Sell	33,812 -805	-2%	-$13K	﹤0.01%	909
2022 Q2	$488K	Buy	34,617 +15,674	+83%	+$293K	﹤0.01%	953
2022 Q1	$459K	Buy	18,943 +7,785	+70%	+$188K	﹤0.01%	1004
2021 Q4	$260K	Buy	+11,158	New	+$224K	﹤0.01%	1212